Emails can get lost in a noisy inbox. In case you missed our recent newsletters, here’s a rundown of the 3 most-popular articles, to get you back up to speed:
The guidance describes the approach sponsors should use to identify if and how real-world data (RWD) and real-world evidence (RWE) are incorporated into their regulatory submissions.
Recent clinical studies are taking new approaches to targeted therapy for ALS, including using a platform trial design, investigating secondary endpoints, and using brain-computer interfaces.
Learn about the internal project that Astellas initiated on decentralized clinical trial technologies and their use in clinical trials that helped prepare them for the pandemic.
This website uses cookies to ensure you get the best experience on our website. Learn more
